A nonoligomerizing mutant form of helicobacter pylori vaca allows structural analysis of the p33 domain

Infection and Immunity

Volumn 84, Issue 9, 2016, Pages 2662-2670

  González Rivera, Christian ^a,c   Campbell, Anne M ^a   Rutherford, Stacey A ^a   PyburnT M , Tasia M ^a   Foegeding, Nora J ^a   Barke, Theresa L ^a   Spiller, Benjamin W ^a   McClain, Mark S ^a   Ohi, Melanie D ^a   Borden Lacy, D ^a,b   Covera, Timothy L ^a,b  

^a and Immunology ^*  (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; PROTEIN P33; PROTEIN P55; VACUOLATING TOXIN; BACTERIAL PROTEIN; BACTERIAL TOXIN; ION CHANNEL; VACA PROTEIN, HELICOBACTER PYLORI;

AMINO TERMINAL SEQUENCE; ARTICLE; BETA HELIX; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CRYSTAL STRUCTURE; ELECTRON MICROSCOPY; FEMALE; HELICOBACTER PYLORI; HOST CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; PROTEIN SECRETION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; GENETICS; HELA CELL LINE; METABOLISM; MUTATION; PROCEDURES; TUMOR CELL LINE;

BACTERIAL PROTEINS; BACTERIAL TOXINS; CELL LINE, TUMOR; HELA CELLS; HELICOBACTER PYLORI; HUMANS; ION CHANNELS; MICROSCOPY, ELECTRON; MUTATION; PROTEIN DOMAINS;

EID: 84984817886     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00254-16     Document Type: Article

References (70)

1. Atherton JC, Blaser MJ. 2009. Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J Clin Invest 119:2475-2487. http://dx.doi.org/10.1172/JCI38605.
2. Cover TL, Blaser MJ. 2009. Helicobacter pylori in health and disease. Gastroenterology 136:1863-1873. http://dx.doi.org/10.1053/j.gastro.2009.01.073.
3. Gilbreath JJ, Cody WL, Merrell DS, Hendrixson DR. 2011. Change is good: variations in common biological mechanisms in the epsilonproteobacterial genera Campylobacter and Helicobacter. Microbiol Mol Biol Rev 75:84-132. http://dx.doi.org/10.1128/MMBR.00035-10.
4. Rieder G, Fischer W, Haas R. 2005. Interaction of Helicobacter pylori with host cells: function of secreted and translocated molecules. Curr Opin Microbiol 8:67-73. http://dx.doi.org/10.1016/j.mib.2004.12.004.
5. Zanotti G, Cendron L. 2014. Structural and functional aspects of the Helicobacter pylori secretome. World J Gastroenterol 20:1402-1423. http://dx.doi.org/10.3748/wjg.v20.i6.1402.
6. Snider CA, Voss BJ, McDonald WH, Cover TL. 2016. Growth phasedependent composition of the Helicobacter pylori exoproteome. J Proteomics 130:94-107. http://dx.doi.org/10.1016/j.jprot.2015.08.025.
7. Cover TL, Blanke SR. 2005. Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat Rev Microbiol 3:320-332. http://dx.doi.org/10.1038/nrmicro1095.
8. Boquet P, Ricci V. 2012. Intoxication strategy of Helicobacter pylori VacA toxin. Trends Microbiol 20:165-174. http://dx.doi.org/10.1016/j.tim.2012.01.008.
9. Kim IJ, Blanke SR. 2012. Remodeling the host environment: modulation of the gastric epithelium by the Helicobacter pylori vacuolating toxin (VacA). Front Cell Infect Microbiol 2:37.
10. Foegeding NJ, Caston RR, McClain MS, Ohi MD, Cover TL. 2016. An overview of Helicobacter pylori VacA toxin biology. Toxins 8:173. http://dx .doi.org/10.3390/toxins8060173.
11. Leunk RD, Johnson PT, David BC, Kraft WG, Morgan DR. 1988. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol 26:93-99. http://dx.doi.org/10.1099/00222615-26-2-93.
12. Cover TL, Blaser MJ. 1992. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem 267:10570-10575.
13. Gebert B, Fischer W, Weiss E, Hoffman R, Haas R. 2003. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 301:1099-1102. http://dx.doi.org/10.1126/science.1086871.
14. Boncristiano M, Paccani SR, Barone S, Ulivieri C, Patrussi L, Ilver D, Amedei A, D'Elios MM, Telford JL, Baldari CT. 2003. The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms. J Exp Med 198:1887-1897. http://dx.doi.org/10.1084/jem.20030621.
15. Sundrud MS, Torres VJ, Unutmaz D, Cover TL. 2004. Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proc Natl Acad Sci U S A 101:7727-7732. http://dx.doi.org/10.1073/pnas.0401528101.
16. Torres VJ, Van Compernolle SE, Sundrud MS, Unutmaz D, Cover TL. 2007. Helicobacter pylori vacuolating cytotoxin inhibits activationinduced proliferation of human T and B lymphocyte subsets. J Immunol 179:5433-5440. http://dx.doi.org/10.4049/jimmunol.179.8.5433.
17. Czajkowsky DM, Iwamoto H, Cover TL, Shao Z. 1999. The vacuolating toxin from Helicobacter pylori forms hexameric pores in lipid bilayers at low pH. Proc Natl Acad SciUSA96:2001-2006. http://dx.doi.org/10.1073/pnas.96.5.2001.
18. Szabo I, Brutsche S, Tombola F, Moschioni M, Satin B, Telford JL, Rappuoli R, Montecucco C, Papini E, Zoratti M. 1999. Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity. EMBO J 18:5517-5527. http://dx.doi.org/10.1093/emboj/18.20.5517.
19. Iwamoto H, Czajkowsky DM, Cover TL, Szabo G, Shao Z. 1999. VacA from Helicobacter pylori: a hexameric chloride channel. FEBS Lett 450:101-104. http://dx.doi.org/10.1016/S0014-5793(99)00474-3.
20. Vinion-Dubiel AD, McClain MS, Czajkowsky DM, Iwamoto H, Ye D, Cao P, Schraw W, Szabo G, Blanke SR, Shao Z, Cover TL. 1999. A dominant negative mutant of Helicobacter pylori vacuolating toxin (VacA) inhibits VacA-induced cell vacuolation. J Biol Chem 274:37736-37742. http://dx.doi.org/10.1074/jbc.274.53.37736.
21. McClain MS, Iwamoto H, Cao P, Vinion-Dubiel AD, Li Y, Szabo G, Shao Z, Cover TL. 2003. Essential role of a GXXXG motif for membrane channel formation by Helicobacter pylori vacuolating toxin. J Biol Chem 278:12101-12108. http://dx.doi.org/10.1074/jbc.M212595200.
22. Cover TL. 2016. Helicobacter pylori diversity and gastric cancer risk. mBio 7:e01869-15. http://dx.doi.org/10.1128/mBio.01869-15.
23. Gangwer KA, Shaffer CL, Suerbaum S, Lacy DB, Cover TL, Bordenstein SR. 2010. Molecular evolution of the Helicobacter pylori vacuolating toxin gene vacA. J Bacteriol 192:6126-6135. http://dx.doi.org/10.1128/JB.01081-10.
24. Atherton JC, Cao P, Peek RM, Jr, Tummuru MK, Blaser MJ, Cover TL. 1995. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori:association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 270:17771-17777.
25. Rhead JL, Letley DP, Mohammadi M, Hussein N, Mohagheghi MA, Eshagh Hosseini M, Atherton JC. 2007. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 133:926-936. http://dx.doi.org/10.1053/j.gastro.2007.06.056.
26. Lupetti P, Heuser JE, Manetti R, Massari P, Lanzavecchia S, Bellon PL, Dallai R, Rappuoli R, Telford JL. 1996. Oligomeric and subunit structure of the Helicobacter pylori vacuolating cytotoxin. J Cell Biol 133:801-807. http://dx.doi.org/10.1083/jcb.133.4.801.
27. Cover TL, Hanson PI, Heuser JE. 1997. Acid-induced dissociation of VacA, the Helicobacter pylori vacuolating cytotoxin, reveals its pattern of assembly. J Cell Biol 138:759-769. http://dx.doi.org/10.1083/jcb.138.4.759.
28. Lanzavecchia S, Bellon PL, Lupetti P, Dallai R, Rappuoli R, Telford JL. 1998. Three-dimensional reconstruction of metal replicas of the Helicobacter pylori vacuolating cytotoxin. J Struct Biol 121:9-18. http://dx.doi .org/10.1006/jsbi.1997.3941.
29. Adrian M, Cover TL, Dubochet J, Heuser JE. 2002. Multiple oligomeric states of the Helicobacter pylori vacuolating toxin demonstrated by cryoelectron microscopy. J Mol Biol 318:121-133. http://dx.doi.org/10.1016/S0022-2836(02)00047-5.
30. El-Bez C, Adrian M, Dubochet J, Cover TL. 2005. High-resolution structural analysis of Helicobacter pylori VacA toxin oligomers by cryonegative staining electron microscopy. J Struct Biol 151:215-228. http://dx.doi.org/10.1016/j.jsb.2005.07.001.
31. Chambers MG, Pyburn TM, Gonzalez-Rivera C, Collier SE, Eli I, Yip CK, Takizawa Y, Lacy DB, Cover TL, Ohi MD. 2013. Structural analysis of the oligomeric states of Helicobacter pylori VacA toxin. J Mol Biol 425:524-535. http://dx.doi.org/10.1016/j.jmb.2012.11.020.
32. Genisset C, Galeotti CL, Lupetti P, Mercati D, Skibinski DA, Barone S, Battistutta R, de Bernard M, Telford JL. 2006. A Helicobacter pylori vacuolating toxin mutant that fails to oligomerize has a dominant negative phenotype. Infect Immun 74:1786-1794. http://dx.doi.org/10.1128/IAI.74.3.1786-1794.2006.
33. Ivie SE, McClain MS, Torres VJ, Algood HM, Lacy DB, Yang R, Blanke SR, Cover TL. 2008. Helicobacter pylori VacA subdomain required for intracellular toxin activity and assembly of functional oligomeric complexes. Infect Immun 76:2843-2851. http://dx.doi.org/10.1128/IAI.01664-07.
34. Cover TL, Tummuru MKR, Cao P, Thompson SA, Blaser MJ. 1994. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem 269:10566-10573.
35. Schmitt W, Haas R. 1994. Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: structural similarities with the IgA protease type of exported protein. Mol Microbiol 12:307-319. http://dx.doi.org/10.1111/j.1365-2958.1994.tb01019.x.
36. Telford JL, Ghiara P, Dell'Orco M, Comanducci M, Burroni D, Bugnoli M, Tecce MF, Censini S, Covacci A, Xiang Z, Papini E, Montecucco C, Parente L, Rappuoli R. 1994. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med 179:1653-1658. http://dx.doi.org/10.1084/jem.179.5.1653.
37. Fischer W, Buhrdorf R, Gerland E, Haas R. 2001. Outer membrane targeting of passenger proteins by the vacuolating cytotoxin autotransporter of Helicobacter pylori. Infect Immun 69:6769-6775. http://dx.doi .org/10.1128/IAI.69.11.6769-6775.2001.
38. Voss BJ, Gaddy JA, McDonald WH, Cover TL. 2014. Analysis of surfaceexposed outer membrane proteins in Helicobacter pylori. J Bacteriol 196:2455-2471. http://dx.doi.org/10.1128/JB.01768-14.
39. Ye D, Blanke SR. 2002. Functional complementation reveals the importance of intermolecular monomer interactions for Helicobacter pylori VacA vacuolating activity. Mol Microbiol 43:1243-1253. http://dx.doi.org/10.1046/j.1365-2958.2002.02818.x.
40. Torres VJ, McClain MS, Cover TL. 2004. Interactions between p-33 and p-55 domains of the Helicobacter pylori vacuolating cytotoxin (VacA). J Biol Chem 279:2324-2331. http://dx.doi.org/10.1074/jbc.M310159200.
41. Torres VJ, Ivie SE, McClain MS, Cover TL. 2005. Functional properties of the p33 and p55 domains of the Helicobacter pylori vacuolating cytotoxin. J Biol Chem 280:21107-21114. http://dx.doi.org/10.1074/jbc .M501042200.
42. Gonzalez-Rivera C, Gangwer KA, McClain MS, Eli IM, Chambers MG, Ohi MD, Lacy DB, Cover TL. 2010. Reconstitution of Helicobacter pylori VacA toxin from purified components. Biochemistry 49:5743-5752. http://dx.doi.org/10.1021/bi100618g.
43. Reyrat JM, Lanzavecchia S, Lupetti P, de Bernard M, Pagliaccia C, Pelicic V, Charrel M, Ulivieri C, Norais N, Ji X, Cabiaux V, Papini E, Rappuoli R, Telford JL. 1999. 3D imaging of the 58-kDa cell binding subunit of the Helicobacter pylori cytotoxin. J Mol Biol 290:459-470. http://dx.doi.org/10.1006/jmbi.1999.2877.
44. de Bernard M, Burroni D, Papini E, Rappuoli R, Telford J, Montecucco C. 1998. Identification of the Helicobacter pylori VacA toxin domain active in the cell cytosol. Infect Immun 66:6014-6016.
45. Ye D, Willhite DC, Blanke SR. 1999. Identification of the minimal intracellular vacuolating domain of the Helicobacter pylori vacuolating toxin. J Biol Chem 274:9277-9282. http://dx.doi.org/10.1074/jbc.274.14.9277.
46. Galmiche A, Rassow J, Doye A, Cagnol S, Chambard JC, Contamin S, de Thillot V, Just I, Ricci V, Solcia E, Van Obberghen E, Boquet P. 2000. The N-terminal 34-kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J 19:6361-6370. http://dx.doi.org/10.1093/emboj/19.23.6361.
47. Domanska G, Motz C, Meinecke M, Harsman A, Papatheodorou P, Reljic B, Dian-Lothrop EA, Galmiche A, Kepp O, Becker L, Gunnewig K, Wagner R, Rassow J. 2010. Helicobacter pylori VacA toxin/subunit p34: targeting of an anion channel to the inner mitochondrial membrane. PLoS Pathog 6:e1000878. http://dx.doi.org/10.1371/journal.ppat.1000878.
48. Foo JH, Culvenor JG, Ferrero RL, Kwok T, Lithgow T, Gabriel K. 2010. Both the p33 and p55 subunits of the Helicobacter pylori VacA toxin are targeted to mammalian mitochondria. J Mol Biol 401:792-798. http://dx .doi.org/10.1016/j.jmb.2010.06.065.
49. Ye D, Blanke SR. 2000. Mutational analysis of the Helicobacter pylori vacuolating toxin amino terminus: identification of amino acids essential for cellular vacuolation. Infect Immun 68:4354-4357. http://dx.doi.org/10.1128/IAI.68.7.4354-4357.2000.
50. McClain MS, Cao P, Cover TL. 2001. Amino-terminal hydrophobic region of Helicobacter pylori vacuolating cytotoxin (VacA) mediates transmembrane protein dimerization. Infect Immun 69:1181-1184. http://dx .doi.org/10.1128/IAI.69.2.1181-1184.2001.
51. McClain MS, Czajkowsky DM, Torres VJ, Szabo G, Shao Z, Cover TL. 2006. Random mutagenesis of Helicobacter pylori vacA to identify amino acids essential for vacuolating cytotoxic activity. Infect Immun 74:6188-6195. http://dx.doi.org/10.1128/IAI.00915-06.
52. Gangwer KA, Mushrush DJ, Stauff DL, Spiller B, McClain MS, Cover TL, Lacy DB. 2007. Crystal structure of the Helicobacter pylori vacuolating toxin p55 domain. Proc Natl Acad Sci U S A 104:16293-16298. http://dx .doi.org/10.1073/pnas.0707447104.
53. Ivie SE, McClain MS, Algood HM, Lacy DB, Cover TL. 2010. Analysis of a beta-helical region in the p55 domain of Helicobacter pylori vacuolating toxin. BMC Microbiol 10:60. http://dx.doi.org/10.1186/1471-2180-10-60.
54. Junker M, Schuster CC, McDonnell AV, Sorg KA, Finn MC, Berger B, Clark PL. 2006. Pertactin beta-helix folding mechanism suggests common themes for the secretion and folding of autotransporter proteins. Proc Natl Acad Sci U S A 103:4918-4923. http://dx.doi.org/10.1073/pnas.0507923103.
55. Kim S, Chamberlain AK, Bowie JU. 2004. Membrane channel structure of Helicobacter pylori vacuolating toxin: role of multiple GXXXG motifs in cylindrical channels. Proc Natl Acad Sci U S A 101:5988-5991. http://dx .doi.org/10.1073/pnas.0308694101.
56. Vaidya M, Panchal H. 2012. In silico investigation and structural characterization of virulent factor and a metallo peptidase present in Helicobacter pylori strain J99. Interdiscip Sci 4:302-309. http://dx.doi.org/10.1007/s12539-012-0145-6.
57. Hawrylik SJ, Wasilko DJ, Haskell SL, Gootz TD, Lee SE. 1994. Bisulfite or sulfite inhibits growth of Helicobacter pylori. J Clin Microbiol 32:790-792.
58. Jimenez-Soto LF, Rohrer S, Jain U, Ertl C, Sewald X, Haas R. 2012. Effects of cholesterol on Helicobacter pylori growth and virulence properties in vitro. Helicobacter 17:133-139. http://dx.doi.org/10.1111/j.1523-5378.2011.00926.x.
59. Shaffer CL, Gaddy JA, Loh JT, Johnson EM, Hill S, Hennig EE, McClain MS, McDonald WH, Cover TL. 2011. Helicobacter pylori exploits a unique repertoire of type IV secretion system components for pilus assembly at the bacterium-host cell interface. PLoS Pathog 7:e1002237. http://dx .doi.org/10.1371/journal.ppat.1002237.
60. Schmidt TG, Skerra A. 2007. The Strep-tag system for one-step purification and high-affinity detection or capturing of proteins. Nat Protoc 2:1528-1535. http://dx.doi.org/10.1038/nprot.2007.209.
61. de Bernard M, Papini E, de Filippis V, Gottardi E, Telford J, Manetti R, Fontana A, Rappuoli R, Montecucco C. 1995. Low pH activates the vacuolating toxin of Helicobacter pylori, which becomes acid and pepsin resistant. J Biol Chem 270:23937-23940. http://dx.doi.org/10.1074/jbc.270.41.23937.
62. McClain MS, Schraw W, Ricci V, Boquet P, Cover TL. 2000. Acidactivation of Helicobacter pylori vacuolating cytotoxin (VacA) results in toxin internalization by eukaryotic cells. Mol Microbiol 37:433-442. http://dx.doi.org/10.1046/j.1365-2958.2000.02013.x.
63. Cover TL, Puryear W, Pérez-Pérez GI, Blaser MJ. 1991. Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin. Infect Immun 59:1264-1270.
64. Gupta VR, Patel HK, Kostolansky SS, Ballivian RA, Eichberg J, Blanke SR. 2008. Sphingomyelin functions as a novel receptor for Helicobacter pylori VacA. PLoS Pathog 4:e1000073. http://dx.doi.org/10.1371/journal .ppat.1000073.
65. Radin JN, Gonzalez-Rivera C, Frick-Cheng AE, Sheng J, Gaddy JA, Rubin DH, Algood HM, McClain MS, Cover TL. 2014. Role of connexin 43 in Helicobacter pylori VacA-induced cell death. Infect Immun 82:423-432. http://dx.doi.org/10.1128/IAI.00827-13.
66. Otwinowski Z, Minor W. 1997. Processing of x-ray diffraction data collected in oscillation mode. Methods Enzymol 276:307-326. http://dx.doi .org/10.1016/S0076-6879(97)76066-X.
67. Vagin A, Teplyakov A. 1997. MOLREP: an automated program for molecular replacement. J Appl Crystallogr 30:1022-1025. http://dx.doi.org/10.1107/S0021889897006766.
68. Emsley P, Cowtan K. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60:2126-2132. http://dx.doi .org/10.1107/S0907444904019158.
69. Nguyen VQ, Caprioli RM, Cover TL. 2001. Carboxy-terminal proteolytic processing of Helicobacter pylori vacuolating toxin. Infect Immun 69:543-546. http://dx.doi.org/10.1128/IAI.69.1.543-546.2001.
70. Torres VJ, McClain MS, Cover TL. 2006. Mapping of a domain required for protein-protein interactions and inhibitory activity of a Helicobacter pylori dominant-negative VacA mutant protein. Infect Immun 74:2093-2101. http://dx.doi.org/10.1128/IAI.74.4.2093-2101.2006.